Biosimilar Retacrit® (epoetin zeta) in the treatment of chemotherapy-induced symptomatic anemia in hematology and oncology in Germany (ORHEO) - non-interventional study.
Onco Targets Ther
; 10: 1295-1305, 2017.
Article
en En
| MEDLINE
| ID: mdl-28280364
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Tipo de estudio:
Clinical_trials
/
Diagnostic_studies
/
Observational_studies
Idioma:
En
Revista:
Onco Targets Ther
Año:
2017
Tipo del documento:
Article